# Benef: __Thorough study of anti-coronavirus drugs__ (PBN__Benef_64)

## Property: has_Beneficiary

* [researchers](../Stakeholder/PBN__Stakeholder_2)
* [scientists](../Stakeholder/PBN__Stakeholder_46)

## Property: has_BenefDetails

Ontological representation of missing drug information enables comprehensive study and analysis of anti-coronavirus drugs, aiding in the design of effective treatments.

## Property: has_BenefSource

* [he_cido_2020](../Article/PBN__Article_13)

## Property: has_BenefReturn

* [Private investors can benefit indirectly from the improved understanding and analysis of anti-coronavirus drugs, potentially leading to better-targeted and more effective treatments, attracting investment and commercial interest.](../BenefReturn/PBN__BenefReturn_64)

